Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Brion

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Neuroscience Letters|January 12, 2002
Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1A Boutajangout, K Leroy, N Touchet, et al.
Neuroscience Letters|December 11, 2003
Mutant presenilin 1 proteins induce cell death and reduce tau-dependent processes outgrowthK Leroy, A Boutajangout, J Richardson, et al.
The American Journal of Tropical Medicine and Hygiene|June 5, 2001
Diagnosis of malaria in non-endemic countries by the ParaSight-F testM P Brenier-Pinchart, C Pinel, A Croisonnier, et al.
The Biochemical Journal|January 1, 1991
Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation siteJ P Brion, D P Hanger, M T Bruce, et al.
The Biochemical Journal|April 1, 1991
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylatedD P Hanger, J P Brion, J M Gallo, et al.
Biological Psychiatry|July 1, 1999
Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrationsS Lovestone, D R Davis, M T Webster, et al.
Neuroreport|June 19, 1998
Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormalityD Cotter, R Kerwin, S al-Sarraji, et al.
Neuroreport|November 14, 1997
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenesJ Brownlees, N G Irving, J P Brion, et al.
Acta Neuropathologica|January 1, 1989
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodiesP N Leigh, A Probst, G E Dale, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Neuroscience Letters|January 12, 2002
Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1A Boutajangout, K Leroy, N Touchet, et al.
Neuroscience Letters|December 11, 2003
Mutant presenilin 1 proteins induce cell death and reduce tau-dependent processes outgrowthK Leroy, A Boutajangout, J Richardson, et al.
The American Journal of Tropical Medicine and Hygiene|June 5, 2001
Diagnosis of malaria in non-endemic countries by the ParaSight-F testM P Brenier-Pinchart, C Pinel, A Croisonnier, et al.
The Biochemical Journal|January 1, 1991
Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation siteJ P Brion, D P Hanger, M T Bruce, et al.
The Biochemical Journal|April 1, 1991
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylatedD P Hanger, J P Brion, J M Gallo, et al.
Biological Psychiatry|July 1, 1999
Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrationsS Lovestone, D R Davis, M T Webster, et al.
Neuroreport|June 19, 1998
Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormalityD Cotter, R Kerwin, S al-Sarraji, et al.
Neuroreport|November 14, 1997
Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenesJ Brownlees, N G Irving, J P Brion, et al.
Acta Neuropathologica|January 1, 1989
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodiesP N Leigh, A Probst, G E Dale, et al.
Pageof 14